1. Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP. (October 2014) Authors: Bigal, Marcelo E; Walter, Sarah; Bronson, Michele; Alibhoy, Abbas; Escandon, Rafael Journal: Cephalalgia Issue: Volume 34:Number 12(2014) Page Start: 968 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reversal of Apixaban and Rivaroxaban Anticoagulation by Andexanet Alfa in ANNEXA-A and ANNEX-R as Assessed by Non-Tissue Factor-Initiated Thrombin Generation Independent of Tissue Factor Pathway Inhibitor. Issue 1 (11th October 2018) Authors: Lu, Genmin; Lin, Joyce; Bronson, Michele; Crowther, Mark; Conley, Pamela B.; Curnutte, John T. Journal: European medical journal Issue: Volume 6:Issue 1(2018:Oct. 11) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program. (June 2014) Authors: Bigal, Marcelo E; Escandon, Rafael; Bronson, Michele; Walter, Sarah; Sudworth, Maria; Huggins, John P; Garzone, Pamela Journal: Cephalalgia Issue: Volume 34:Number 7(2014) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗